Literature DB >> 23831026

BACE1 regulates hippocampal astrogenesis via the Jagged1-Notch pathway.

Xiangyou Hu1, Wanxia He, Xiaoyang Luo, Katherine Elyse Tsubota, Riqiang Yan.   

Abstract

BACE1 is the sole secretase for generating β-amyloid (Aβ) in vivo and is being actively pursued as a drug target for the treatment of Alzheimer's disease. Transmembrane BACE1 exerts its biological activity by cleaving its membrane-bound cellular substrates. Here, we reveal that BACE1 directly regulates the level of membrane-anchored full-length Jagged1 (Jag1), a signaling molecule important for the control of neurogenesis and astrogenesis, via interaction with its cognate Notch receptor. We show that shedding of Jag1 is reduced in BACE1 null mice and upregulated Jag1 enhances Notch signaling via cell-cell juxtacrine interactions. Additional biochemical assays confirmed that overexpression of BACE1 enhanced cleavage of Jag1. Consequently, BACE1 null mice exhibit a significant increase in astrogenesis with a corresponding decrease in neurogenesis in their hippocampi during early development. Hence, BACE1 appears to function as a signaling protease that controls the balance of neurogenesis and astrogenesis via the Jag1-Notch pathway.
Copyright © 2013 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23831026      PMCID: PMC3740554          DOI: 10.1016/j.celrep.2013.06.005

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  40 in total

1.  Transient Notch activation initiates an irreversible switch from neurogenesis to gliogenesis by neural crest stem cells.

Authors:  S J Morrison; S E Perez; Z Qiao; J M Verdi; C Hicks; G Weinmaster; D J Anderson
Journal:  Cell       Date:  2000-05-26       Impact factor: 41.582

Review 2.  Milestones of neuronal development in the adult hippocampus.

Authors:  Gerd Kempermann; Sebastian Jessberger; Barbara Steiner; Golo Kronenberg
Journal:  Trends Neurosci       Date:  2004-08       Impact factor: 13.837

3.  Membrane-anchored aspartyl protease with Alzheimer's disease beta-secretase activity.

Authors:  R Yan; M J Bienkowski; M E Shuck; H Miao; M C Tory; A M Pauley; J R Brashier; N C Stratman; W R Mathews; A E Buhl; D B Carter; A G Tomasselli; L A Parodi; R L Heinrikson; M E Gurney
Journal:  Nature       Date:  1999-12-02       Impact factor: 49.962

4.  Purification and cloning of amyloid precursor protein beta-secretase from human brain.

Authors:  S Sinha; J P Anderson; R Barbour; G S Basi; R Caccavello; D Davis; M Doan; H F Dovey; N Frigon; J Hong; K Jacobson-Croak; N Jewett; P Keim; J Knops; I Lieberburg; M Power; H Tan; G Tatsuno; J Tung; D Schenk; P Seubert; S M Suomensaari; S Wang; D Walker; J Zhao; L McConlogue; V John
Journal:  Nature       Date:  1999-12-02       Impact factor: 49.962

Review 5.  Radial glia and neural stem cells.

Authors:  Paolo Malatesta; Irene Appolloni; Filippo Calzolari
Journal:  Cell Tissue Res       Date:  2007-09-11       Impact factor: 5.249

6.  BACE1 deficiency causes altered neuronal activity and neurodegeneration.

Authors:  Xiangyou Hu; Xiangdong Zhou; Wanxia He; Jun Yang; Wencheng Xiong; Philip Wong; Christopher G Wilson; Riqiang Yan
Journal:  J Neurosci       Date:  2010-06-30       Impact factor: 6.167

7.  Reduced sodium channel Na(v)1.1 levels in BACE1-null mice.

Authors:  Doo Yeon Kim; Manuel T Gersbacher; Perrine Inquimbert; Dora M Kovacs
Journal:  J Biol Chem       Date:  2010-12-29       Impact factor: 5.157

8.  Notch1 and its ligands Delta-like and Jagged are expressed and active in distinct cell populations in the postnatal mouse brain.

Authors:  Gila Stump; André Durrer; Anne-Laurence Klein; Simone Lütolf; Ueli Suter; Verdon Taylor
Journal:  Mech Dev       Date:  2002-06       Impact factor: 1.882

9.  BACE1-/- mice exhibit seizure activity that does not correlate with sodium channel level or axonal localization.

Authors:  Brian D Hitt; Thomas C Jaramillo; Dane M Chetkovich; Robert Vassar
Journal:  Mol Neurodegener       Date:  2010-08-23       Impact factor: 14.195

Review 10.  The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics.

Authors:  John Hardy; Dennis J Selkoe
Journal:  Science       Date:  2002-07-19       Impact factor: 47.728

View more
  37 in total

1.  BACE1 regulates the proliferation and cellular functions of Schwann cells.

Authors:  Xiangyou Hu; Hailong Hou; Chinthasagar Bastian; Wanxia He; Shupeng Qiu; Yingying Ge; Xinhua Yin; Grahame J Kidd; Sylvain Brunet; Bruce D Trapp; Selva Baltan; Riqiang Yan
Journal:  Glia       Date:  2017-02-13       Impact factor: 7.452

Review 2.  A Close Look at BACE1 Inhibitors for Alzheimer's Disease Treatment.

Authors:  Brati Das; Riqiang Yan
Journal:  CNS Drugs       Date:  2019-03       Impact factor: 5.749

Review 3.  Inhibiting BACE1 to reverse synaptic dysfunctions in Alzheimer's disease.

Authors:  Riqiang Yan; Qingyuan Fan; John Zhou; Robert Vassar
Journal:  Neurosci Biobehav Rev       Date:  2016-04-01       Impact factor: 8.989

4.  Axonal and Schwann cell BACE1 is equally required for remyelination of peripheral nerves.

Authors:  Xiangyou Hu; Jinxuan Hu; Lu Dai; Bruce Trapp; Riqiang Yan
Journal:  J Neurosci       Date:  2015-03-04       Impact factor: 6.167

Review 5.  Neurological dysfunctions associated with altered BACE1-dependent Neuregulin-1 signaling.

Authors:  Xiangyou Hu; Qingyuan Fan; Hailong Hou; Riqiang Yan
Journal:  J Neurochem       Date:  2015-11-13       Impact factor: 5.372

6.  β-site amyloid precursor protein cleaving enzyme 1(BACE1) regulates Notch signaling by controlling the cleavage of Jagged 1 (Jag1) and Jagged 2 (Jag2) proteins.

Authors:  Wanxia He; Jinxuan Hu; Yuxing Xia; Riqiang Yan
Journal:  J Biol Chem       Date:  2014-07-25       Impact factor: 5.157

Review 7.  The Roles of the Stem Cell-Controlling Sox2 Transcription Factor: from Neuroectoderm Development to Alzheimer's Disease?

Authors:  Golmaryam Sarlak; Bruno Vincent
Journal:  Mol Neurobiol       Date:  2015-02-18       Impact factor: 5.590

Review 8.  Targeting the β secretase BACE1 for Alzheimer's disease therapy.

Authors:  Riqiang Yan; Robert Vassar
Journal:  Lancet Neurol       Date:  2014-02-17       Impact factor: 44.182

Review 9.  Function, therapeutic potential and cell biology of BACE proteases: current status and future prospects.

Authors:  Robert Vassar; Peer-Hendrik Kuhn; Christian Haass; Matthew E Kennedy; Lawrence Rajendran; Philip C Wong; Stefan F Lichtenthaler
Journal:  J Neurochem       Date:  2014-04-19       Impact factor: 5.372

10.  Loss of Ataxin-1 Potentiates Alzheimer's Pathogenesis by Elevating Cerebral BACE1 Transcription.

Authors:  Jaehong Suh; Donna M Romano; Larissa Nitschke; Scott P Herrick; Britt A DiMarzio; Volodymyr Dzhala; Jun-Seok Bae; Mary K Oram; Yuejiao Zheng; Basavaraj Hooli; Kristina Mullin; Vincenzo A Gennarino; Wilma Wasco; Jeremy D Schmahmann; Mark W Albers; Huda Y Zoghbi; Rudolph E Tanzi
Journal:  Cell       Date:  2019-08-22       Impact factor: 41.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.